
  
    
      
        Background_NNP
        Identification_NNP of_IN vascular_NN endothelial_NN growth_NN factor_NN
        (_( VEGF_NNP )_) /_NN vascular_NN permeability_NN factor_NN (_( VPF_NNP )_) -_: responsive_JJ genes_NNS
        could_MD potentially_RB help_VB elucidate_NN the_DT detail_NN molecular_JJ
        mechanisms_NNS of_IN endothelial_NN cells_NNS (_( EC_NNP )_) activation_NN ._. EC_NNP
        activation_NN is_VBZ a_DT program_NN of_IN gene-expression_JJ that_WDT could_MD
        affect_VB angiogenesis_NNS ,_, permeability_NN ,_, and_CC inflammation_NN that_WDT
        are_VBP closely_RB associated_VBN with_IN a_DT large_JJ number_NN of_IN vascular_NN
        diseases_NNS ._. Recent_JJ studies_NNS show_VBP that_IN priming_VBG of_IN quiescent_JJ ECs_NNP
        with_IN appropriate_JJ cytokines_NNS could_MD switch-on_JJ the_DT EC_NNP
        transcription_NN machinery_NN ,_, the_DT genes_NNS and_CC protein_NN products_NNS of_IN
        which_WDT could_MD activate_VBP ECs_NNP ._. Mediators_NNP known_VBN to_TO activate_VBP ECs_NNP
        include_VBP inflammatory_JJ cytokines_NNS ,_, growth_NN factors_NNS such_JJ as_IN
        VEGF_NNP /_NN VPF_NNP and_CC basic_JJ fibroblast_NN growth_NN factor_NN (_( bFGF_NN )_) ,_,
        extracellular_NN matrix_NN (_( ECM_NNP )_) proteins_NNS such_JJ as_IN collagen_NN and_CC
        fibronectin_NN ,_, and_CC proteases_NNS such_JJ as_IN MMPs_NNP [_NN 1_CD 2_CD ]_NN ._. 
        In_IN vitro_NN and_CC 
        in_IN vivo_NN assays_NNS indicate_VBP that_IN VEGF_NNP
        signaling_VBG promotes_VBZ increased_VBN permeability_NN ,_, cell_NN migration_NN ,_,
        proliferation_NN ,_, and_CC differentiation_NN ,_, functioning_VBG through_IN two_CD
        EC-specific_NNP tyrosine_NN kinase_NN receptor_NN such_JJ as_IN Kinase_NNP domain_NN
        receptor_NN (_( KDR_NNP )_) [_NN 1_CD 2_CD 3_CD ]_NN ._. In_IN the_DT majority_NN of_IN solid_JJ tumors_NNS ,_,
        VEGF_NNP is_VBZ upregulated_JJ in_IN response_NN to_TO hypoxia_NN ,_, inducing_VBG the_DT
        expression_NN of_IN pro-angiogenic_JJ genes_NNS that_WDT promote_VBP tumor_NN
        angiogenesis_NNS ,_, growth_NN and_CC eventual_JJ metastasis_NNS [_NN 3_CD 4_CD 5_CD ]_NN ._.
        The_DT expression_NN of_IN both_DT positive_JJ and_CC negative_JJ factors_NNS must_MD
        be_VB tightly_RB and_CC specifically_RB regulated_VBN in_IN a_DT coordinated_VBN
        manner_NN ._. Uncontrolled_NNP expressions_NNS of_IN these_DT factors_NNS could_MD
        activate_VBP the_DT EC_NNP transcription_NN machinery_NN ,_, which_WDT could_MD
        promote_VB pathological_JJ consequences_NNS including_VBG tumor_NN growth_NN
        and_CC metastasis_NNS [_NN 3_CD 4_CD 5_CD 6_CD ]_NN ._.
        Thus_RB ,_, the_DT identification_NN and_CC dissection_NN of_IN the_DT cellular_JJ
        and_CC molecular_JJ pathways_NNS associated_VBN with_IN EC_NNP activation_NN may_MD
        reveal_VB novel_NN clues_NNS which_WDT could_MD provide_VB further_JJ
        understanding_NN of_IN biological_JJ processes_VBZ such_JJ as_IN wound_VBN
        healing_VBG ,_, vascular_NN permeability_NN ,_, and_CC angiogenesis_NNS among_IN
        others_NNS ._. A_DT number_NN of_IN 
        in_IN vitro_NN model_NN systems_NNS have_VBP thus_RB been_VBN
        developed_VBN to_TO study_VB EC_NNP activation_NN that_WDT employs_VBZ either_DT one_CD or_CC
        more_JJR combinations_NNS of_IN ECM_NNP molecules_NNS including_VBG fibrin_NN ,_,
        fibronectin_NN ,_, collagens_NNS ,_, laminins_NNS ,_, and_CC Matrigel_NNP ®_NN matrices_NNS
        together_RB with_IN PMA_NNP and_CC FGF_NNP [_NN 7_CD 8_CD 9_CD ]_NN ._. When_WRB placed_VBN in_IN a_DT 3_CD D_NNP
        type_NN I_PRP collagen_NN matrix_NN and_CC stimulated_VBN with_IN PMA_NNP ,_, VEGF_NNP ,_, or_CC
        bFGF_NN ,_, ECs_NNP undergo_VBP rapid_JJ morphological_JJ changes_NNS and_CC
        differentiate_VB into_IN capillary-like_JJ tubular_JJ networks_NNS ._.
        Transcriptional_NNP inhibitors_NNS block_VBP this_DT 
        in_IN vitro_NN tube_NN formation_NN ,_, suggesting_VBG
        that_IN the_DT angiogenesis_NNS requires_VBZ EC_NNP activation_NN and_CC gene_NN
        expression_NN [_NN 8_CD 9_CD ]_NN ._. Indeed_RB ,_, a_DT recent_JJ review_NN describes_VBZ
        approaches_NNS used_VBN to_TO identify_VB such_JJ angiogenesis-related_JJ genes_NNS
        [_NN 10_CD ]_NN ._. Although_IN many_JJ angiogenesis-related_JJ soluble_JJ
        factors_NNS ,_, ECM_NNP components_NNS ,_, and_CC intracellular_NN signaling_VBG
        pathways_NNS have_VBP been_VBN identified_VBN and_CC elucidated_JJ ,_, their_PRP$
        subsequent_JJ targets_NNS and_CC their_PRP$ mode_NN of_IN action_NN still_RB remain_VB to_TO
        be_VB determined_VBN ._.
        Despite_IN extensive_JJ studies_NNS ,_, for_IN example_NN ,_, the_DT molecular_JJ
        mechanisms_NNS underlying_VBG endothelial_NN cell_NN activation_NN and_CC EC_NNP
        differentiations_NNS are_VBP not_RB entirely_RB understood_VBN ._. To_TO better_JJR
        understand_VB molecular_JJ mechanisms_NNS and_CC pathways_NNS of_IN EC_NNP
        activation_NN ,_, we_PRP embedded_VBN ECs_NNP in_IN 3_CD D_NNP type_NN I_PRP collagen_NN in_IN
        presence_NN or_CC absence_NN of_IN human_JJ recombinant_JJ VEGF_NNP 165_CD ._. RNAs_NNP
        isolated_VBD from_IN these_DT cultures_NNS were_VBD then_RB subjected_VBN to_TO
        suppression_NN subtractive_JJ hybridization_NN and_CC differential_NN
        display_NN (_( SSHDD_NNP )_) ._. Through_IN this_DT method_NN ,_, we_PRP identified_VBD a_DT set_NN
        of_IN 11_CD new_JJ induced_VBN genes_NNS previously_RB not_RB reported_VBD to_TO be_VB
        associated_VBN with_IN the_DT processes_NNS of_IN EC_NNP activation_NN ._. We_PRP
        confirmed_VBD expressions_NNS of_IN candidate_NN genes_NNS in_IN ECs_NNP by_IN northern_JJ
        and_CC western_JJ blot_NN analyses_NNS ._. There_EX is_VBZ a_DT large_JJ number_NN of_IN
        literature_NN showing_VBG microarray_NN and_CC gene-expression_JJ profiling_VBG
        analysis_NN of_IN EC_NNP transcriptome_NN ._. However_RB ,_, this_DT preliminary_JJ
        study_NN forms_VBZ the_DT basis_NN for_IN the_DT future_JJ experiments_NNS involving_VBG
        analyses_NNS of_IN signaling_VBG pathways_NNS associated_VBN with_IN EC_NNP
        activation_NN that_WDT are_VBP crucial_JJ for_IN many_JJ pathophysiological_JJ
        conditions_NNS including_VBG angiogenesis_NNS ,_, cardiovascular_JJ diseases_NNS
        and_CC growth_NN of_IN solid_JJ tumors_NNS ._.
      
      
        Results_NNS
        
          Identification_NNP of_IN VEGF-responsive_NNP endothelial_NN cell_NN
          genes_NNS using_VBG SSHDD_NNP
          Angioblasts_NNP and_CC ECs_NNP are_VBP the_DT precursor_NN cells_NNS that_WDT can_MD
          form_VB functional_JJ blood_NN vessels_NNS in_IN response_NN to_TO specific_JJ
          angiogenic_JJ stimuli_NNS ._. To_TO study_VB the_DT molecular_JJ mechanisms_NNS
          underlying_VBG capillary_JJ morphogenesis_NNS in_IN ECs_NNP ,_, we_PRP used_VBD a_DT
          well-established_JJ 
          in_IN vitro_NN model_NN of_IN angiogenesis_NNS ._.
          Model_NNP system_NN employed_VBN in_IN our_PRP$ study_NN closely_RB resembles_VBZ with_IN
          those_DT that_WDT have_VBP been_VBN described_VBN previously_RB [_NN 7_CD 8_CD 9_CD ]_NN ._.
          Either_CC human_JJ microvascular_NN endothelial_NN cells_NNS (_( HMECs_NNP )_) or_CC
          human_JJ umbilical_JJ vein_NN endothelial_NN cells_NNS (_( HUVECs_NNP )_) were_VBD
          seeded_VBN between_IN two_CD thin_JJ layers_NNS of_IN type_NN I_PRP collagen_NN gels_NNS ,_,
          and_CC overlayed_JJ with_IN complete_JJ media_NNS supplemented_JJ with_IN VEGF_NNP
          165_CD ,_, as_IN described_VBN in_IN methods_NNS ._. This_DT typically_RB induced_VBN
          cytoplasmic_JJ projections_NNS ,_, spikes_NNS and_CC extensions_NNS ,_,
          elongations_NNS of_IN ECs_NNP within_IN 4_CD to_TO 8_CD hr_NN ._. These_DT processes_NNS were_VBD
          considered_VBN to_TO represent_VB a_DT precursor_NN to_TO cell_NN elongation_NN ,_,
          interconnections_NNS of_IN cells_NNS ,_, and_CC eventual_JJ tubule_NN formation_NN ._.
          A_DT small_JJ population_NN of_IN ECs_NNP that_WDT failed_VBD to_TO elongate_VB ,_, did_VBD
          not_RB form_VB such_JJ interconnections_NNS ._. This_DT model_NN system_NN closely_RB
          approximates_VBZ ECM_NNP proteolysis_NNS ,_, cell_NN migration_NN ,_,
          proliferation_NN ,_, and_CC capillary_JJ formation_NN ._. Representative_NNP
          photomicrographs_NNS of_IN VEGF-induced_NNP capillary_JJ morphogenesis_NNS
          in_IN ECs_NNP after_IN 8_CD hr_NN and_CC 16_CD hr_NN are_VBP shown_VBN in_IN Figs_NNP ._. 1_LS Aand_NNP 1_CD B_NNP ,_,
          respectively_RB ._. Figure_NN 1_CD Cshows_NNP ECs_NNP forming_VBG (_( at_IN 200_CD X_NNP
          magnification_NN )_) elaborate_VB interconnections_NNS and_CC vacuole_NN
          formation_NN at_IN 36_CD hr_NN ._. Although_IN control_NN (_( un-stimulated_JJ )_) ECs_NNP
          formed_VBD interconnections_NNS at_IN the_DT end_NN of_IN 24_CD hr_NN ,_, but_CC fail_VB to_TO
          form_VB any_DT capillaries_NNS (_( data_NNS not_RB shown_VBN )_) ._. Eosin_NNP staining_VBG of_IN
          these_DT structures_NNS demonstrated_VBN that_IN the_DT capillaries_NNS were_VBD
          surrounded_VBN by_IN at_IN least_JJS three_CD to_TO five_CD ECs_NNP (_( Fig_NNP ._. 1_LS D_NNP )_) ._. To_TO
          identify_VB genes_NNS associated_VBN with_IN activation_NN of_IN ECs_NNP ,_, we_PRP used_VBD
          the_DT method_NN of_IN SSHDD_NNP ._. By_IN employing_VBG forward-_NN and_CC
          reverse-subtraction_JJ ,_, we_PRP identified_VBD both_DT common_JJ (_( indicated_VBN
          by_IN arrows_NNS )_) and_CC differentially_RB expressed_VBD genes_NNS (_( Fig_NNP ._.
          1_LS E_NNP &_CC 1_CD F_NN )_) ._. The_DT addition_NN of_IN VEGF_NNP into_IN ECs_NNP embedded_VBN in_IN
          the_DT 3_CD D_NNP type_NN I_PRP collagen_NN matrix_NN (_( forward-subtraction_JJ )_)
          generated_VBN more_JJR than_IN 450_CD cDNA_NN fragments_NNS ._. To_TO eliminate_VB the_DT
          identification_NN of_IN artifactual_NN clones_NNS ,_, we_PRP analyzed_VBD only_RB
          those_DT cDNA_NN fragments_NNS that_WDT were_VBD detected_VBN at_IN least_JJS 4_CD times_NNS ._.
          Based_VBN on_IN this_DT criterion_NN ,_, only_RB 311_CD cDNA_NN fragments_NNS (_( clones_NNS )_)
          out_IN of_IN 450_CD sequences_NNS (_( clones_NNS )_) were_VBD retained_VBN for_IN further_JJ
          evaluation_NN ._. From_IN this_DT 311_CD ,_, a_DT total_JJ number_NN of_IN 32_CD induced_VBN
          fragments_NNS were_VBD identified_VBN and_CC sequenced_JJ (_( Table_NNP I_PRP )_) ._.
          Database_NNP search_NN with_IN these_DT nucleotide_NN sequences_NNS using_VBG the_DT
          BLAST_NN algorithm_NN revealed_VBD many_JJ known_VBN positive_JJ or_CC negative_JJ
          regulators_NNS of_IN angiogenesis_NNS ,_, including_VBG proteases_NNS and_CC cell_NN
          surface_NN receptors_NNS ._. Importantly_NNP ,_, we_PRP identified_VBD 11_CD
          VEGF-responsive_NNP candidate_NN genes_NNS associated_VBN with_IN the_DT
          activation_NN of_IN endothelial_NN cells_NNS ._.
        
        
          Confirmation_NNP of_IN Differentially_NNP Expressed_NNP Genes_NNP by_IN
          Northern_NNP Blot_NNP
          To_TO confirm_VB the_DT differential_NN expression_NN of_IN genes_NNS
          identified_VBN by_IN SSHDD_NNP ,_, we_PRP performed_VBD Northern_NNP blot_NN analysis_NN
          of_IN total_JJ RNA_NNP isolated_VBD from_IN ECs_NNP grown_VBN in_IN 3_CD D_NNP collagen_NN
          matrices_NNS ._. The_DT expression_NN of_IN 5_CD known_VBN regulators_NNS of_IN
          angiogenesis_NNS ,_, KDR_NNP and_CC α_NN 
          2_CD integrin_NN ,_, VE-cadherin_NNP ,_, MMP_NNP 1_CD ,_, and_CC
          MMP_NNP 2_CD ,_, as_RB well_RB as_IN 11_CD candidate_NN genes_NNS (_( Figs_NNP ._. 2_LS ,_, 4_CD ;_: Table_NNP I_PRP )_)
          identified_VBN were_VBD analyzed_VBN ._. Consistent_NNP with_IN previous_JJ
          reports_NNS ,_, the_DT expression_NN of_IN KDR_NNP /_NN VEGFR-_NNP 2_CD increased_VBN by_IN ~_NN 2_CD ._. 5_LS
          fold_VB at_IN 12_CD hours_NNS ,_, ~_NN 2_CD fold_VB at_IN 24_CD hrs_NNS ,_, and_CC ~_NN 1_CD ._. 5_LS fold_VB at_IN 36_CD
          hours_NNS ,_, in_IN response_NN to_TO VEGF_NNP 165_CD treatment_NN (_( Fig_NNP ._. 2_LS A_DT )_) ,_,
          whereas_IN the_DT expression_NN of_IN α_NN 
          2_CD integrin_NN subunit_NN was_VBD increased_VBN by_IN ~_NN 5_CD
          fold_VB at_IN 12_CD hours_NNS ,_, by_IN ~_NN 2_CD fold_VB at_IN 24_CD hrs_NNS ,_, and_CC was_VBD barely_RB
          detectable_JJ at_IN 36_CD hrs_NNS (_( Fig_NNP ._. 2_LS B_NNP )_) [_NN 11_CD 12_CD ]_NN ._. Expression_NNP of_IN
          VE-cadherin_NNP was_VBD minimal_JJ at_IN the_DT earlier_JJR time_NN points_NNS ,_, but_CC
          significantly_RB increased_VBN at_IN the_DT end_NN of_IN 36_CD hours_NNS (_( Fig_NNP ._. 2_LS C_NNP )_) ._.
          MMP_NNP 1_CD expression_NN remained_VBD robustly_RB active_JJ from_IN 12_CD to_TO 36_CD
          hours_NNS (_( Fig_NNP ._. 2_LS D_NNP )_) ._. While_IN expression_NN of_IN MMP_NNP 2_CD appeared_VBD to_TO be_VB
          biphasic_JJ ,_, highest_JJS expressions_NNS were_VBD detected_VBN at_IN 12_CD and_CC 36_CD
          hrs_NNS (_( Fig_NNP ._. 2_LS E_NNP )_) ._. Equal_NNP loading_NN of_IN RNAs_NNP was_VBD confirmed_VBN by_IN
          probing_VBG membrane_NN with_IN a_DT β-actin_JJ cDNA_NN probe_NN (_( data_NNS not_RB
          shown_VBN )_) ._. Northern_JJ analyses_NNS of_IN clones_NNS 7_CD D_NNP ,_, 3_CD B_NNP ,_, 17_CD E_NNP ,_, 22_CD G_NNP ,_,
          33_CD A_DT ,_, 37_CD F_NN ,_, 48_CD A_DT ,_, 54_CD C_NNP ,_, 77_CD D_NNP ,_, 94_CD H_NNP ,_, 263_CD F_NN ,_, and_CC 309_CD C_NNP were_VBD
          performed_VBN at_IN 24_CD hrs_NNS following_VBG VEGF_NNP 165_CD treatment_NN (_( Fig_NNP ._.
          3_LS A_DT ,_, 3_CD B_NNP ,_, 3_CD C_NNP ,_, 3_CD D_NNP ,_, 3_CD E_NNP ,_, 3_CD F_NN ,_, 3_CD G_NNP ,_, 3_CD H_NNP ,_, 3_CD I_PRP ,_, 3_CD J_NNP ,_, 3_CD K_NNP ,_, 3_CD L_NNP )_) ._. Northern_JJ blot_NN
          analysis_NN did_VBD not_RB support_VB the_DT differential_NN expression_NN of_IN
          clone_NN 54_CD C_NNP (_( Fig_NNP ._. 3_LS H_NNP )_) ._. Clone_NNP 7_CD D_NNP ,_, 3_CD B_NNP ,_, and_CC 309_CD C_NNP probes_NNS each_DT
          detected_VBD 2_CD transcripts_NNS ,_, which_WDT could_MD be_VB either_CC
          alternatively_RB spliced_JJ products_NNS or_CC related_VBN genes_NNS ._. Clone_NNP
          17_CD E_NNP ,_, 22_CD G_NNP ,_, 33_CD A_DT ,_, 37_CD F_NN ,_, 48_CD A_DT ,_, 54_CD C_NNP ,_, 77_CD D_NNP ,_, 94_CD H_NNP ,_, 263_CD F_NN probes_NNS
          detected_VBD single_JJ transcripts_NNS (_( Fig_NNP ._.
          3_LS C_NNP ,_, 3_CD D_NNP ,_, 3_CD E_NNP ,_, 3_CD F_NN ,_, 3_CD G_NNP ,_, 3_CD H_NNP ,_, 3_CD I_PRP ,_, 3_CD J_NNP ,_, 3_CD K_NNP )_) ._. Of_IN particular_JJ note_NN ,_, probe_NN 3_CD B_NNP
          (_( corresponding_JJ to_TO Stanniocalcin_NNP )_) detected_VBD primarily_RB the_DT
          lower_JJR isoform_NN (_( 1_CD ._. 9_CD kb_NN )_) in_IN ECs_NNP ._. While_IN probe_NN 309_CD C_NNP
          (_( corresponding_JJ to_TO Stabilin_NNP )_) is_VBZ known_VBN to_TO produce_VB three_CD
          isoforms_NNS ._. Most_JJS likely_JJ ,_, ECs_NNP primarily_RB express_VBP Stabilin-_NNP 1_CD
          and_CC -_: 2_CD that_WDT are_VBP 7_CD ._. 8_CD and_CC 6_CD ._. 2_CD kbs_NNS isoforms_NNS respectively_RB ._.
          The_DT GAPDH_NNP probe_NN was_VBD included_VBN as_IN a_DT control_NN for_IN the_DT
          quantity_NN and_CC integrity_NN of_IN the_DT loaded_VBN RNA_NNP ,_, detecting_VBG a_DT
          single_JJ transcript_NN of_IN ~_NN 1_CD ._. 3_LS kb_NN ._. All_DT data_NNS shown_VBN are_VBP
          representative_NN of_IN those_DT obtained_VBN in_IN at_IN least_JJS three_CD
          separate_JJ experiments_NNS ,_, with_IN similar_JJ results_NNS ._.
        
        
          Confirmation_NNP of_IN Differentially_NNP Expressed_NNP Genes_NNP by_IN
          Western_NNP Blot_NNP
          To_TO confirm_VB that_IN the_DT genes_NNS identified_VBN by_IN SSHDD_NNP encode_NN
          proteins_NNS ,_, we_PRP performed_VBD Western_JJ blot_NN analysis_NN of_IN total_JJ
          cellular_JJ protein_NN isolated_VBN from_IN ECs_NNP grown_VBN in_IN monolayers_NNS ._.
          The_DT addition_NN of_IN bFGF_NN ,_, VEGF_NNP ,_, or_CC PMA_NNP to_TO the_DT monolayers_NNS ECs_NNP
          induced_VBD cellular_JJ elongation_NN over_IN a_DT period_NN of_IN 8_CD to_TO 24_CD hr_NN ._.
          In_IN contrast_NN ,_, unstimulated_JJ ECs_NNP remained_VBD proliferative_JJ and_CC
          retained_VBD a_DT cobblestone_NN appearance_NN (_( data_NNS not_RB shown_VBN )_) ._.
          Western_JJ blot_NN analysis_NN revealed_VBD that_IN VEGF_NNP and_CC PMA_NNP ,_, but_CC not_RB
          bFGF_NN ,_, induced_VBD the_DT expression_NN of_IN KDR_NNP ,_, Flt-_NNP 1_CD ,_, and_CC the_DT α_NN 
          2_CD integrin_NN subunit_NN at_IN 48_CD hr_NN (_( Fig_NNP ._.
          4_LS A_DT ,_, 4_CD B_NNP ,_, 4_CD C_NNP )_) ._. Likewise_RB ,_, only_RB VEGF_NNP and_CC PMA_NNP upregulated_JJ the_DT
          expression_NN of_IN VE-Cadherin_NNP (_( Fig_NNP ._. 4_LS D_NNP )_) ._. As_IN expected_VBN ,_, all_DT 3_CD
          cytokines_NNS induced_VBD the_DT expression_NN of_IN MMP-_NNP 1_CD and_CC MMP-_NNP 2_CD (_( Fig_NNP ._.
          4_LS Eand_NNP 4_CD F_NN )_) ._. These_DT cytokines_NNS also_RB induced_VBN expression_NN of_IN
          Kinesin_NNP (_( Fig_NNP ._. 4_LS G_NNP )_) ,_, albeit_IN less_RBR appreciably_RB ._. Furthermore_RB ,_,
          we_PRP found_VBD dramatic_JJ increase_NN in_IN expression_NN of_IN VCIP_NNP /_NN PAP_NNP 2_CD b_SYM in_IN
          ECs_NNP that_WDT were_VBD stimulated_VBN with_IN VEGF_NNP and_CC PMA_NNP (_( Fig_NNP ._. 4_LS H_NNP ,_, lane_NN
          3_CD and_CC 4_LS )_) ,_, in_IN contrast_NN ,_, in_IN bFGF_NN stimulated_VBN cells_NNS (_( Fig_NNP ._. 4_LS ,_,
          lane_NN 2_LS )_) or_CC in_IN control_NN (_( Fig_NNP ._. 4_LS ,_, lane_NN 1_LS )_) its_PRP$ expression_NN
          remained_VBD undetectable_JJ ._. Anti-_NNP Grb_NNP 2_CD mAb_NN was_VBD included_VBN as_IN
          control_NN for_IN protein_NN loading_NN (_( Fig_NNP ._. 4_LS I_PRP )_) ._. These_DT data_NNS suggest_VBP
          that_IN the_DT cDNA_NN fragments_NNS detected_VBN by_IN SSHDD_NNP were_VBD indeed_RB
          active_JJ genes_NNS that_WDT produce_VBP proteins_NNS that_WDT could_MD activate_VBP
          endothelial_NN cells_NNS ._. Similar_JJ studies_NNS will_MD be_VB required_VBN to_TO
          test_VB whether_IN remaining_VBG novel_NN genes_NNS produce_VBP functional_JJ
          proteins_NNS or_CC not_RB and_CC to_TO establish_VB their_PRP$ exact_JJ role_NN in_IN EC_NNP
          activation_NN ._. For_IN Western_NNP immunoblotting_VBG experiment_NN ,_,
          monolayer_NN ECs_NNP as_IN opposed_VBN to_TO cells_NNS grown_VBN in_IN 3_CD D_NNP gel_NN were_VBD
          used_VBN ._. Because_IN ,_, it_PRP was_VBD difficult_JJ to_TO solubilize_NN ECs_NNP
          embedded_VBN in_IN 3_CD D_NNP gel_NN ._. Cold_NNP cell_NN extraction_NN buffer_NN
          containing_VBG 1_CD ._. 25_CD %_NN Triton_NNP X-_NNP 100_CD and_CC 0_CD ._. 1_CD %_NN SDS_NNP did_VBD not_RB
          effectively_RB solubilize_NN solidified_VBD 3_CD D_NNP collagen_NN ,_, -_: warm_JJ
          (_( 37_CD °_NN C_NNP )_) cell_NN extraction_NN buffer_NN was_VBD incompatible_JJ because_IN it_PRP
          activated_VBN endogenous_JJ proteases_NNS ._. It_PRP remains_VBZ possible_JJ that_IN
          different_JJ genes_NNS may_MD be_VB expressed_VBN in_IN ECs_NNP cultured_JJ as_IN
          monolayer_NN as_IN opposed_VBN to_TO 3_CD D_NNP ._.
        
      
      
        Discussion_NNP
        
          Known_VBN Regulators_NNS of_IN Angiogenesis_NNP
          Of_IN the_DT known_VBN regulators_NNS of_IN EC_NNP activation_NN identified_VBN in_IN
          our_PRP$ study_NN ,_, the_DT role_NN of_IN MMPs_NNP has_VBZ been_VBN well_RB established_VBN ._.
          Matrix_NNP digestion_NN by_IN MMPs_NNP ,_, including_VBG MMP-_NNP 1_CD ,_, MMP-_NNP 2_CD ,_, and_CC
          MMP-_NNP 9_CD ,_, is_VBZ a_DT pre-requisite_JJ for_IN EC_NNP activation_NN ,_,
          differentiation_NN ,_, and_CC tumor_NN induced_VBD angiogenesis_NNS [_NN 16_CD 17_CD ]_NN
          ._. The_DT growth_NN of_IN mesenchymal_NN cells_NNS in_IN a_DT 3_CD D_NNP type_NN I_PRP collagen_NN
          matrix_NN induces_VBZ the_DT processing_NN and_CC activation_NN of_IN pro-_JJ MMP-_NNP 2_CD
          by_IN MMP-_NNP 1_CD ._. Consistent_NNP with_IN this_DT ,_, incubation_NN of_IN ECs_NNP with_IN
          angiogenic_JJ cytokines_NNS induced_VBD the_DT expression_NN of_IN MMP-_NNP 1_CD and_CC
          MMP-_NNP 2_CD (_( Figs_NNP ._. 2_LS &_CC 4_LS )_) ._.
          We_PRP also_RB identified_VBD 4_CD indirect_JJ regulators_NNS of_IN EC_NNP
          activation_NN and_CC angiogenesis_NNS ,_, i_NNP ._. e_SYM ._. ,_, myeloblastin_NN ,_,
          cathepsin_NN B_NNP ,_, calpastatin_NN ,_, and_CC urokinase_NN plasminogen_NN
          activator_NN surface_NN receptor_NN (_( u-_NN PAR_NNP )_) ._. The_DT myeloblastin_NN
          protein_NN displays_VBZ anti-proliferative_JJ properties_NNS and_CC is_VBZ
          also_RB a_DT key_JJ protease_NN involved_VBN in_IN factor-independent_JJ growth_NN
          of_IN hematopoietic_JJ cells_NNS [_NN 18_CD ]_NN ._. Overexpression_NNP of_IN
          myeloblastin_NN has_VBZ been_VBN linked_VBN to_TO multifunctional_NN cytokine_NN
          transforming_VBG growth_NN factor-β_JJ (_( TGF-β_NNP )_) a_DT known_VBN regulator_NN of_IN
          angiogenesis_NNS ._. We_PRP postulate_NN that_DT myeloblastin_NN in_IN our_PRP$ model_NN
          system_NN may_MD negatively_RB regulate_VB EC_NNP activation_NN ,_, thereby_RB
          signaling_VBG to_TO end_VB EC_NNP morphogenic_JJ differentiation_NN ._.
          Cathepsin_NNP B_NNP is_VBZ a_DT lysosomal_NN cysteine_NN protease_NN ,_, the_DT
          expression_NN of_IN which_WDT is_VBZ increased_VBN in_IN different_JJ tumors_NNS ,_,
          including_VBG human_JJ brain_NN ,_, lung_NN ,_, colon_NN ,_, and_CC breast_NN tumors_NNS [_NN
          19_CD ]_NN ._. Calpastatin_NNP is_VBZ a_DT physiological_JJ protease_NN inhibitor_NN
          that_IN acts_NNS specifically_RB on_IN calpain_NN ,_, a_DT calcium-dependent_JJ
          cysteine_NN protease_NN ._. The_DT cleavage_NN of_IN calpastatin_NN by_IN
          caspases_NNS initiates_NNS the_DT apoptotic_JJ cascade_NN in_IN certain_JJ
          neurological_JJ disorders_NNS [_NN 20_CD ]_NN ._. It_PRP is_VBZ possible_JJ that_WDT
          increased_VBN expression_NN of_IN calpastatin_NN may_MD control_VB calpain_NN
          activity_NN thereby_RB limiting_VBG extent_NN of_IN proteolysis_NNS during_IN
          capillary_JJ sprouting_VBG ._. In_IN contrast_NN ,_, uPAR_NN has_VBZ been_VBN shown_VBN to_TO
          regulate_VB plasminogen-mediated_JJ extracellular_NN proteolysis_NNS
          during_IN angiogenesis_NNS [_NN 21_CD ]_NN ._.
          The_DT identification_NN of_IN VEGFR-_NNP 1_CD and_CC VEGFR-_NNP 2_CD (_( KDR_NNP )_) was_VBD
          consistent_JJ with_IN the_DT observation_NN that_IN the_DT stimulation_NN of_IN
          ECs_NNP with_IN VEGF_NNP increases_NNS the_DT expression_NN of_IN VEGFR-_NNP 2_CD ,_,
          promoting_VBG myocardial_NN revascularization_NN [_NN 22_CD ]_NN ._. We_PRP also_RB
          detected_VBD the_DT cell_NN adhesion_NN molecules_NNS VCAM-_NNP 1_CD ,_, VE-Cadherin_NNP ,_,
          and_CC the_DT α_NN 
          2_CD integrin_NN subunit_NN ,_, all_DT known_VBN
          regulators_NNS of_IN angiogenesis_NNS ._. In_IN the_DT present_JJ study_NN ,_, we_PRP
          confirmed_VBD the_DT expression_NN of_IN KDR_NNP ,_, α_NN 
          2_CD integrin_NN ,_, VE-cadherin_NNP ,_, MMP_NNP 1_CD ,_, and_CC
          MMP_NNP 2_CD in_IN activated_VBN ECs_NNP by_IN northern_JJ and_CC western_JJ blot_NN
          analysis_NN (_( Figs_NNP ._. 2_LS and_CC 4_LS )_) ._.
          Finally_RB ,_, we_PRP identified_VBD a_DT known_VBN modulator_NN of_IN
          angiogenesis_NNS ,_, the_DT prostaglandin_NN endoperoxidase-_NN H_NNP
          synthase_NN ,_, also_RB known_VBN as_IN cyclooxygenase_NN (_( COX_NNP )_) ._. The_DT COX-_NNP 1_CD
          isoform_NN is_VBZ constitutively_RB expressed_VBN in_IN blood_NN vessels_NNS ,_,
          while_IN expression_NN of_IN the_DT COX-_NNP 2_CD isoform_NN is_VBZ induced_VBN in_IN new_JJ
          blood_NN vessels_NNS ._. In_IN many_JJ angiogenic_JJ tumors_NNS COX-_NNP 2_CD
          colocalizes_NNS with_IN VEGF_NNP and_CC TGF-β_NNP ,_, and_CC increased_VBN expression_NN
          of_IN COX-_NNP 2_CD and_CC VEGF_NNP has_VBZ been_VBN correlated_JJ with_IN increased_VBN
          tumor_NN microvascular_NN density_NN [_NN 23_CD ]_NN ._.
        
        
          Metabolic_NNP genes_NNS and_CC Miscellaneous_JJ genes_NNS
          Although_IN metabolic_JJ genes_NNS such_JJ as_IN ketohexokinase_NN ,_,
          adenosine_NN deaminase_NN ,_, and_CC spermidine_NN synthase_NN detected_VBN by_IN
          SSHDD_NNP assay_NN 
          per_IN se_FW do_VBP not_RB directly_RB activate_VBP of_IN
          EC_NNP ,_, it_PRP is_VBZ likely_JJ that_IN they_PRP could_MD represent_VB a_DT component_NN of_IN
          the_DT "_'' angiogenic_JJ switch_NN "_'' ._. Among_IN the_DT miscellaneous_JJ genes_NNS
          identified_VBN in_IN our_PRP$ study_NN were_VBD adenylyl_NN cyclase_NN and_CC
          platelet_NN factor_NN 4_CD (_( PF_NNP 4_LS )_) ._. Intracellular_NNP signaling_VBG
          machinery_NN of_IN adenylyl_NN cyclase_NN is_VBZ required_VBN for_IN
          cytoskeletal_NN organization_NN ,_, vessel_NN maturation_NN ,_, and_CC vessel_NN
          integrity_NN [_NN 24_CD ]_NN ._. PF_NNP 4_CD is_VBZ a_DT chemokine_NN that_IN binds_NNS to_TO FGF_NNP
          and_CC is_VBZ a_DT known_VBN inhibitor_NN of_IN EC_NNP proliferation_NN and_CC
          migration_NN [_NN 25_CD ]_NN ._. Thus_RB ,_, the_DT upregulation_NN of_IN PF_NNP 4_CD might_MD
          limit_VB the_DT degree_NN of_IN activation_NN of_IN ECs_NNP and_CC morphogenic_JJ
          differentiation_NN ._. It_PRP is_VBZ noteworthy_JJ that_IN Stanniocalcin_NNP
          (_( Stc_NNP ;_: accession_NN #_# U_NNP 25997_CD ;_: Figs_NNP ._. 3_LS A_DT )_) was_VBD also_RB identified_VBN
          by_IN GeneCalling_NNP (_( a_DT mRNA_NN profiling_VBG technique_NN )_) and_CC 
          in_IN situ_NN hybridization_NN demonstrated_VBN
          that_IN Stc_NNP is_VBZ expressed_VBN in_IN the_DT vasculature_NN of_IN a_DT subset_NN of_IN
          squamous_JJ cell_NN carcinomas_NNS [_NN 26_CD ]_NN ._. Stc_NNP is_VBZ a_DT secreted_JJ
          protein_NN known_VBN to_TO regulate_VB calcium_NN and_CC phosphate_NN
          homeostasis_NNS ,_, potential_JJ role_NN of_IN this_DT protein_NN in_IN EC_NNP
          activation_NN and_CC permeability_NN is_VBZ not_RB clear_JJ [_NN 27_CD ]_NN ._. Since_IN
          most_JJS ECM-degrading_NNP enzymes_NNS are_VBP metal_NN ion_NN dependent_JJ ,_, Stc_NNP
          may_MD act_VB as_IN a_DT sensor_NN to_TO maintain_VB a_DT steady-state_JJ level_NN of_IN
          metal_NN ions_NNS during_IN EC_NNP activation_NN ._.
        
        
          Candidate_NNP genes_NNS associated_VBN with_IN the_DT activation_NN of_IN
          ECs_NNP
          In_IN addition_NN to_TO the_DT genes_NNS discussed_VBN above_IN that_DT have_VBP
          previously_RB been_VBN implicated_VBN in_IN EC_NNP activation_NN and_CC
          differentiation_NN ,_, we_PRP also_RB identified_VBD 11_CD candidate_NN genes_NNS
          (_( Table_NNP I_PRP )_) ._.
          Kinesin_NNP heavy_JJ chain_NN (_( KHC_NNP ;_: accession_NN #_# X_NNP 65873_CD ;_: Figs_NNP ._.
          3_LS Band_NNP 4_CD G_NNP )_) ,_, mediates_NNS organelle_NN movement_NN towards_IN the_DT plus_CC
          ends_NNS of_IN microtubules_NNS in_IN the_DT presence_NN of_IN ATP_NNP and_CC functions_NNS
          in_IN cell_NN differentiation_NN and_CC axonal_NN guidance_NN [_NN 28_CD ]_NN ._. To_TO
          our_PRP$ knowledge_NN ,_, increased_VBN expression_NN of_IN KHC_NNP during_IN EC_NNP
          differentiation_NN has_VBZ not_RB been_VBN previously_RB reported_VBN ._.
          Although_IN the_DT specific_JJ role_NN of_IN KHC_NNP in_IN the_DT differentiation_NN
          process_NN is_VBZ unclear_JJ ,_, this_DT protein_NN might_MD be_VB important_JJ for_IN
          the_DT maintenance_NN of_IN the_DT plasticity_NN and_CC /_NN or_CC polarity_NN of_IN ECs_NNP ,_,
          which_WDT may_MD be_VB a_DT prerequisite_NN for_IN the_DT formation_NN of_IN
          capillary_JJ ends_NNS ._.
          Epiregulin_NNP (_( Fig_NNP ._. 3_LS C_NNP )_) is_VBZ a_DT member_NN of_IN epidermal_NN growth_NN
          factor_NN (_( EGF_NNP )_) family_NN of_IN mitogens_NNS [_NN 29_CD ]_NN ._. Expression_NNP of_IN
          epiregulin_NN has_VBZ been_VBN reported_VBN to_TO be_VB highest_JJS in_IN placenta_NN
          and_CC in_IN a_DT subset_NN of_IN carcinoma_NN cells_NNS ._. Epiregulin_NNP activates_NNS
          COX-_NNP 2_CD ,_, therefore_RB ,_, epiregulin_NN may_MD serve_VB as_IN an_DT upstream_RB
          inflammatory_JJ component_NN of_IN COX-_NNP 2_CD signaling_VBG pathway_NN ._. The_DT
          function_NN of_IN epiregulin_NN in_IN the_DT activation_NN of_IN ECs_NNP has_VBZ not_RB
          been_VBN investigated_VBN ._.
          A_DT general_JJ transcription_NN factor_NN BTF_NNP 3_CD (_( Fig_NNP ._. 3_LS D_NNP ,_, clone_NN
          22_CD G_NNP ,_, accession_NN #_# AA_NN 130020_CD )_) protein_NN is_VBZ thought_VBN to_TO be_VB
          involved_VBN in_IN precise_JJ transcription_NN by_IN RNA_NNP polymerase_NN II_NNP ,_,
          but_CC fails_VBZ to_TO interact_NN with_IN DNA_NNP ._. Disruption_NNP of_IN gene_NN
          encoding_VBG BTF_NNP 3_CD protein_NN in_IN the_DT mouse_NN caused_VBD
          postimplantation_NN lethality_NN around_IN embryonic_JJ day_NN 6_CD ._. 5_CD [_NN 30_CD
          ]_NN ._. Detailed_NNP studies_NNS have_VBP not_RB been_VBN reported_VBN in_IN the_DT
          literature_NN ._. We_PRP believe_VBP ,_, this_DT is_VBZ the_DT first_JJ report_NN of_IN
          identification_NN of_IN BTF_NNP 3_CD as_IN one_CD of_IN the_DT induced_VBN genes_NNS in_IN the_DT
          activation_NN of_IN ECs_NNP ._.
          As_IN a_DT first_JJ step_NN towards_IN elucidating_VBG the_DT molecular_JJ
          mechanisms_NNS and_CC pathways_NNS associated_VBN with_IN activation_NN of_IN
          ECs_NNP ,_, we_PRP cloned_VBN the_DT full-length_JJ cDNA_NN corresponding_JJ to_TO the_DT
          Clone_NNP 33_CD A_DT called_VBN VCIP_NNP ,_, also_RB known_VBN as_IN phosphatidic_JJ acid_NN
          phosphatase_NN type_NN 2_CD b_SYM (_( PAP_NNP 2_CD b_SYM )_) ._. PAP_NNP 2_CD b_SYM shares_NNS similarity_NN with_IN
          
          Drosophila_NNP polarity_NN gene_NN 
          Wunen-_NNP 2_CD [_NN 31_CD 32_CD ]_NN ._. PAP_NNP 2_CD b_SYM /_NN VCIP_NNP
          encodes_NNS 311_CD amino_JJ acid_NN residues_NNS ,_, contains_VBZ a_DT single_JJ
          N-_NNP glycosylation_NN site_NN ,_, a_DT consensus_NN lipid_NN phosphatase_NN motif_NN
          (_( KPSXXXRPH_NNP )_) ,_, an_DT RGD_NNP cell_NN attachment_NN motif_NN ,_,
          six-transmembrane_JJ channel-like_JJ structure_NN ,_, and_CC displays_NNS Mg_NNP
          +_NN +_NN independent_JJ lipid_NN phosphatase_NN activity_NN in_IN transfected_JJ
          293_CD T_NN cells_NNS [_NN 32_CD ]_NN ._. Both_DT N-_NNP and_CC C-_NNP terminus_JJ segments_NNS of_IN
          PAP_NNP 2_CD b_SYM /_NN VCIP_NNP are_VBP located_VBN inside_IN the_DT cytoplasm_NN ._. Consistent_NNP
          with_IN previously_RB published_VBN report_NN our_PRP$ data_NNS suggest_VBP that_IN
          PAP_NNP 2_CD b_SYM /_NN VCIP_NNP is_VBZ cell_NN surface_NN protein_NN and_CC the_DT expression_NN of_IN
          VCIP_NNP is_VBZ highly_RB enriched_JJ in_IN vascularized_JJ tissues_NNS ._. In_IN
          addition_NN to_TO its_PRP$ known_VBN lipid_NN phosphatase_NN activity_NN ,_,
          PAP_NNP 2_CD b_SYM /_NN VCIP_NNP also_RB mediate_VB cell-cell_JJ interactions_NNS [_NN 31_CD ]_NN
          ._.
          Synaptojanin-_NNP 2_CD (_( Figure_NN 4_CD F_NN )_) is_VBZ also_RB known_VBN as_IN a_DT
          polyphosphoinositide_NN phosphatase-_NN 2_CD ._. This_DT family_NN of_IN
          proteins_NNS is_VBZ distant_JJ homolog_NN of_IN yeast_NN protein_NN SacI_NNP [_NN 33_CD ]_NN
          ._. The_DT SacI_NNP homology_NN domain_NN is_VBZ most_RBS notably_RB found_VBD at_IN the_DT
          amino_JJ terminal_NN of_IN the_DT inositol_NN 5_CD '_POS -_: phosphatase_NN
          synaptojanin_NN ._. Synaptojanin-_NNP 2_CD (_( lipid_NN phosphatase_NN )_)
          activities_NNS may_MD be_VB regulated_VBN by_IN cell-cell_JJ and_CC cell_NN matrix_NN
          interactions_NNS through_IN RAFTs_NNP '_POS morphogenetic_JJ '_POS platforms_NNS [_NN 34_CD
          ]_NN ._.
          G_NNP protein-coupled_JJ receptor_NN (_( GPCR_NNP )_) kinase-interactor-_JJ 2_CD
          (_( Fig_NNP ._. 3_LS G_NNP )_) interacts_NNS with_IN G_NNP protein-coupled_JJ receptor_NN
          kinases_NNS ,_, and_CC exhibits_VBZ ADP-ribosylation_NNP factor_NN (_( ARF_NNP )_)
          GTPase-activating_NNP protein_NN (_( GAP_NNP )_) activity_NN ._. It_PRP is_VBZ known_VBN
          have_VBP several_JJ isoforms_NNS ,_, alternatively_RB sliced_JJ products_NNS ,_,
          however_RB ,_, we_PRP primarily_RB detected_VBD a_DT single_JJ transcript_NN of_IN 5_CD ._. 2_CD
          kb_NN size_NN (_( EC_NNP specific_JJ isoform_NN ?_. )_) ._. Because_IN GIT-_NNP 2_CD localizes_NNS
          with_IN a_DT subset_NN of_IN paxillin_NN ,_, therefore_RB ,_, makes_VBZ it_PRP a_DT
          potential_JJ candidate_NN signaling_VBG protein_NN that_WDT may_MD
          collaborate_VB with_IN focal_JJ adhesion_NN signaling_VBG machinery_NN [_NN 35_CD
          ]_NN ._. Thus_RB ,_, GIT-_NNP 2_CD may_MD play_VB a_DT role_NN in_IN cell_NN adhesion_NN ,_,
          spreading_VBG ,_, and_CC motility_NN ._.
          SMAP_NNP ,_, an_DT Smg_NNP GDS-associating_NNP protein_NN (_( Fig_NNP ._. 3_LS H_NNP ,_, Clone_NNP
          54_CD C_NNP ,_, accession_NN #_# AI_NNP 401257_CD )_) ,_, contains_VBZ 9_CD Armadillo_NNP '_POS repeats_VBZ
          and_CC interacts_NNS with_IN the_DT smg_NN GDS_NNP protein_NN through_IN these_DT
          repeats_NNS ._. This_DT protein_NN is_VBZ a_DT v-_NN Src_NNP substrate_NN ,_,
          phosporylation_NN affects_VBZ the_DT affinity_NN of_IN the_DT protein_NN for_IN
          smg_NN GDS_NNP ._. The_DT small_JJ G_NNP protein_NN GDP_NNP dissociation_NN stimulator_NN
          (_( smg_NN GDS_NNP )_) acts_NNS on_IN a_DT group_NN of_IN small_JJ G_NNP proteins_NNS including_VBG
          the_DT Rho_NNP and_CC Rap_NNP 1_CD family_NN members_NNS and_CC Ki-_NNP Ras_NNP ._. Smg_NNP GDS_NNP
          exhibits_VBZ dual_JJ activity_NN ._. One_CD is_VBZ to_TO stimulate_VB their_PRP$ GDP_NNP /_NN GTP_NNP
          exchange_NN reactions_NNS ,_, and_CC the_DT other_JJ is_VBZ to_TO inhibit_VB their_PRP$
          interactions_NNS with_IN membranes_NNS [_NN 36_CD ]_NN ._.
          Angiopoietin_NNP related_VBD protein_NN (_( AngRP_NNP )_) (_( Fig_NNP ._. 3_LS I_PRP )_) is_VBZ
          chiefly_RB expressed_VBN by_IN the_DT hepatic_JJ cells_NNS ._. AngRP_NNP contain_VB the_DT
          characteristic_JJ coiled-coil_JJ and_CC fibrinogen-like_JJ domains_NNS
          that_WDT are_VBP conserved_JJ in_IN angiopoietins_NNS ,_, however_RB ,_, do_VBP not_RB
          interact_NN with_IN Tie-_NNP 1_CD and_CC Tie-_NNP 2_CD receptor_NN [_NN 37_CD ]_NN ._. AngRP_NNP act_NN
          as_IN a_DT survival_NN factor_NN for_IN ECs_NNP ,_, but_CC its_PRP$ role_NN in_IN
          angiogenesis_NNS is_VBZ not_RB clear_JJ ._. It_PRP will_MD be_VB interesting_JJ to_TO
          examine_VB if_IN there_EX is_VBZ a_DT specific_JJ receptor_NN for_IN this_DT molecule_NN
          in_IN ECs_NNP or_CC other_JJ vascular_NN cells_NNS ._.
          Probe_NNP 94_CD H_NNP (_( Fig_NNP ._. 3_LS J_NNP )_) detected_VBD 0_CD ._. 8_CD kb_NN transcript_NN ,_, amino_JJ
          acid_NN sequence_NN analysis_NN suggest_VBP that_IN this_DT protein_NN is_VBZ
          likely_JJ to_TO be_VB member_NN of_IN ribosomal_JJ protein_NN L_NNP 19_CD [_NN 38_CD ]_NN ._. In_IN
          eukaryotes_NNS ,_, ribosome_NN consists_VBZ of_IN a_DT 60_CD S_NNP large_JJ subunit_NN and_CC
          a_DT 40_CD S_NNP small_JJ subunit_NN [_NN 39_CD ]_NN ._. In_IN mammalian_JJ cells_NNS ,_,
          ribosomal_JJ proteins_NNS accounts_NNS for_IN up_IN to_TO 12_CD %_NN of_IN the_DT total_JJ
          cellular_JJ protein_NN ._.
          The_DT alpha_NN subunit_NN of_IN Translational_NNP elongation_NN factor-_NN 1_CD
          (_( Fig_NNP ._. 3_LS K_NNP )_) mediates_NNS binding_JJ of_IN aminoacyl-t_JJ RNAs_NNP to_TO 80_CD S_NNP
          ribosomes_NNS ._. This_DT process_NN is_VBZ driven_VBN by_IN hydrolysis_NNS of_IN GTP_NNP
          into_IN GDP_NNP ._. Translational_NNP elongation_NN factor-_NN 1_CD interacts_NNS
          with_IN guanine_NN nucleotides_NNS ,_, 80_CD S_NNP ribosomes_NNS ,_, and_CC
          aminoacyl-t_JJ RNAs_NNP ._. In_IN addition_NN ,_, Translational_NNP elongation_NN
          factor-_NN 1_CD binds_NNS with_IN the_DT β_NN subunit_NN of_IN Translational_NNP
          elongation_NN factor-_NN 1_CD to_TO exchange_VB bound_VBN GDP_NNP for_IN GTP_NNP [_NN 41_CD ]_NN
          ._.
          Finally_RB ,_, clone_NN 309_CD C_NNP (_( Fig_NNP ._. 3_LS L_NNP )_) DNA_NN sequence_NN was_VBD
          identical_JJ with_IN stabilin-_NN 1_CD ._. Stabilin_NNP has_VBZ been_VBN described_VBN as_IN
          an_DT endothelial-macrophage_JJ member_NN of_IN the_DT fasciclin_NN domain_NN
          containing_VBG protein_NN ._. Stabilin-_NNP 1_CD and_CC -_: 2_CD are_VBP homologous_RB
          transmembrane_NN proteins_NNS showing_VBG 7_CD fasciclin-like_JJ adhesion_NN
          domains_NNS ,_, 18_CD -_: 20_CD EGF_NNP domains_NNS ,_, 1_CD X-_NNP link_NN domain_NN and_CC 3_CD -_: 6_CD
          B-X_NNP (_( 7_CD )_) -_: B_NNP hyaluronan-binding_JJ motifs_NNS [_NN 40_CD ]_NN ._. Stabilin-_NNP 1_CD
          and_CC stabilin-_NN 2_CD are_VBP likely_JJ to_TO play_VB a_DT role_NN in_IN cell-cell_JJ and_CC
          cell-matrix_JJ interactions_NNS in_IN vascular_NN cells_NNS [_NN 40_CD ]_NN ._.
          Several_JJ articles_NNS describe_VBP the_DT identification_NN of_IN genes_NNS
          associated_VBN with_IN the_DT activation_NN of_IN ECs_NNP and_CC angiogenesis_NNS ,_,
          as_RB well_RB as_IN the_DT repertoire_NN of_IN genes_NNS expressed_VBD in_IN normal_JJ
          versus_CC tumor-associated_JJ endothelium_NN [_NN 42_CD 43_CD 44_CD 45_CD ]_NN ._.
          Because_IN EC_NNP activation_NN is_VBZ a_DT complex_JJ process_NN ,_, accompanied_VBN
          by_IN alterations_NNS in_IN many_JJ aspects_NNS of_IN EC_NNP physiology_NN ,_, it_PRP was_VBD
          not_RB surprising_VBG that_IN the_DT genes_NNS identified_VBN in_IN these_DT studies_NNS
          were_VBD in_IN several_JJ functional_JJ classes_NNS ._. However_RB ,_, the_DT genes_NNS
          identified_VBN in_IN the_DT present_JJ study_NN are_VBP significantly_RB
          different_JJ from_IN those_DT reported_VBN by_IN others_NNS ,_, which_WDT may_MD
          reflect_VB differences_NNS in_IN the_DT approaches_NNS used_VBN and_CC types_NNS of_IN
          tissues_NNS analyzed_VBD [_NN 42_CD 43_CD 44_CD 45_CD ]_NN ._. This_DT preliminary_JJ study_NN
          serves_VBZ as_IN groundwork_NN for_IN our_PRP$ laboratory_NN ,_, and_CC we_PRP believe_VBP ,_,
          it_PRP will_MD be_VB worthwhile_JJ to_TO examine_VB their_PRP$ role_NN in_IN ECs_NNP ._.
          Detail_NNP study_NN of_IN these_DT candidate_NN genes_NNS will_MD entail_VB
          generation_NN of_IN recombinant_JJ cDNA_NN constructs_NNS ,_, generation_NN of_IN
          cell_NN lines_NNS ,_, antibodies_NNS ,_, fusion_NN proteins_NNS ,_, and_CC perform_VB
          in-situ_JJ hybridization_NN among_IN others_NNS ._. Detailed_NNP analysis_NN of_IN
          each_DT of_IN the_DT differentially_RB expressed_VBN genes_NNS identified_VBN in_IN
          this_DT report_NN is_VBZ ongoing_JJ and_CC is_VBZ beyond_IN the_DT scope_NN of_IN this_DT
          article_NN ._.
        
      
      
        Methods_NNP
        
          Materials_NNS
          HUVECs_NNP were_VBD purchased_VBN from_IN Clonetics_NNP (_( CA_NNP )_) ._. Most_JJS cell_NN
          culture_NN reagents_NNS were_VBD purchased_VBN from_IN InVitrogen_NNP Corp_NNP ._.
          Oligonucleotide_NNP primers_NNS were_VBD purchased_VBN from_IN
          Sigma-_NNP Genosys_NNP ;_: recombinant_JJ human_JJ VEGF_NNP (_( VEGF_NNP 165_CD )_) ,_, bFGF_NN ,_,
          anti-_NN VEGF_NNP (_( MAB_NNP 293_CD )_) ,_, and_CC anti-_NN MMP_NNP 1_CD (_( MAB_NNP 900_CD )_) from_IN R_NN &_CC D_NNP
          Systems_NNPS ;_: adult_NN human_JJ serum-_NN AB_NNP ,_, from_IN Gemini_NNP Bioproducts_NNP ;_:
          and_CC bovine_JJ skin-derived_JJ type_NN I_PRP collagen_NN ,_, from_IN Cohesion_NNP
          Inc_NNP ._. Affinity-purified_NNP anti-α_JJ 
          2_CD β_NN 
          1_CD integrin_NN (_( MAB_NNP 1988_CD )_) ,_, anti-α_JJ 
          v_NN β_NN 
          3_CD integrin_NN (_( LM_NNP 609_CD )_) ,_, anti-_NN MMP_NNP 2_CD
          (_( MAB_NNP 13405_CD )_) ,_, and_CC anti-_NN VE-cadherin_NNP (_( MAB_NNP 1989_CD )_) monoclonal_NN
          antibodies_NNS (_( mAbs_NNS )_) were_VBD purchased_VBN from_IN Chemicon_NNP Intl_NNP ;_:
          anti-_NN Flt-_NNP 1_CD (_( sc-_NN 316_CD )_) ,_, anti-_NN KDR_NNP (_( sc-_NN 6251_CD )_) ,_, anti-_NN Kinesin_NNP
          heavy_JJ chain_NN (_( sc-_NN 13359_CD )_) ,_, anti-_NN Stanniocalcin_NNP (_( sc-_NN 14352_CD )_) ,_,
          and_CC anti-_NN Grb_NNP 2_CD were_VBD obtained_VBN from_IN Santa_NNP Cruz_NNP Biotechnology_NNP
          Inc_NNP ._. ,_, and_CC anti-β_JJ 
          1_CD integrin_NN subunit_NN mAbs_NNS (_( 4_CD B_NNP 4_LS )_) ,_, from_IN
          Coulter_NNP Inc_NNP ._. Rabbit_NNP anti-α_JJ 
          2_CD integrin_NN subunit_NN polyclonal_NN
          antibodies_NNS (_( pAbs_NNS )_) were_VBD a_DT kind_NN gift_NN from_IN Dr_NNP ._. Guido_NNP Tarone_NNP
          (_( University_NNP of_IN Torino_NNP Pavia_NNP ,_, Italy_NNP )_) ._. Anti-_NNP MHC_NNP class_NN II_NNP
          (_( W_NNP 6_CD /_NN 32_CD )_) was_VBD purchased_VBN from_IN Sigma_NNP ._. Anti-_NNP VCIP_NNP /_NN PAP_NNP 2_CD b-_NN RGD_NNP
          antibody_NN was_VBD generated_VBN by_IN immunizing_VBG rabbit_NN with_IN a_DT
          synthetic_JJ peptide_NN modeled_VBD after_IN 20_CD amino_JJ acid_NN residues_NNS of_IN
          VCIP_NNP /_NN PAP_NNP 2_CD b_SYM (_( EGYIQNYRCRGDDSKVQEAR_NNP )_) [_NN 31_CD ]_NN ._.
        
        
          Cell_NNP Culture_NNP
          Monolayer_NNP cell_NN culture_NN was_VBD performed_VBN as_RB previously_RB
          described_VBD [_NN 46_CD 47_CD ]_NN ._. To_TO induce_VB capillary_JJ formation_NN ,_,
          unstarved_JJ proliferating_VBG HUVECs_NNP (_( passage_NN 4_LS )_) were_VBD gently_RB
          resuspended_JJ (_( at_IN 6_CD ×_NN 10_CD 5_CD cells_NNS /_NN ml_NN )_) in_IN a_DT 3_CD D_NNP collagen_NN matrix_NN
          that_WDT was_VBD prepared_VBN by_IN mixing_VBG 7_CD ml_NN of_IN 3_CD ._. 0_CD mg_NN /_NN ml_NN type_NN I_PRP
          collagen_NN solution_NN with_IN 1_CD ml_NN of_IN 10_CD X_NNP M_NNP 199_CD medium_NN at_IN 4_CD °_NN C_NNP ,_,
          adjusting_VBG the_DT pH_NN to_TO 7_CD ._. 5_CD with_IN 0_CD ._. 1_CD N_NNP sodium_NN hydroxide_NN ,_,
          adding_VBG 0_CD ._. 1_CD ml_NN of_IN 100_CD X_NNP ITS_NNP ,_, and_CC the_DT final_JJ volume_NN to_TO 10_CD ml_NN
          with_IN sterile_JJ distilled_VBN water_NN ._. The_DT cells_NNS were_VBD then_RB seeded_VBN
          in_IN 24_CD -_: well_RB tissue_NN culture_NN dishes_NNS and_CC the_DT matrix_NN was_VBD
          allowed_VBN to_TO polymerize_NN for_IN 30_CD minutes_NNS at_IN 37_CD °_NN C_NNP ._. The_DT matrix_NN
          was_VBD subsequently_RB layered_JJ with_IN M_NNP 199_CD medium_NN containing_VBG 20_CD %_NN
          adult_NN human_JJ serum-_NN AB_NNP ,_, 4_CD mM_NN L-_NNP glutamine_NN ,_, 1_CD X_NNP ITS_NNP ,_, and_CC 100_CD
          ng_NN /_NN ml_NN VEGF_NNP 165_CD ._. The_DT growth_NN medium_NN was_VBD supplemented_JJ with_IN
          fresh_JJ VEGF_NNP 165_CD every_DT 6_CD hours_NNS ._. The_DT old_JJ growth_NN medium_NN was_VBD
          removed_VBN and_CC fresh_JJ medium_NN +_NN VEGF_NNP added_VBD every_DT 24_CD hours_NNS ._.
        
        
          Suppression_NN Subtractive_NNP Hybridization_NNP and_CC
          Differential_NNP Display_NNP (_( SSHDD_NNP )_)
          HUVECs_NNP were_VBD cultured_JJ in_IN a_DT 3_CD D_NNP collagen_NN matrix_NN for_IN 0_CD ,_,
          12_CD ,_, 24_CD ,_, 36_CD ,_, 48_CD ,_, and_CC 72_CD hours_NNS ,_, with_IN or_CC without_IN VEGF_NNP 165_CD and_CC
          total_JJ RNA_NNP was_VBD extracted_VBN with_IN TRIzol_NNP ®_NN Reagent_NNP (_( Invitrogen_NNP
          Corp_NNP )_) ._. Integrity_NNP of_IN the_DT RNA_NNP was_VBD determined_VBN by_IN 1_CD ._. 2_CD %_NN
          agarose-formaldehyde_JJ gel_NN electrophoresis_NNS ._. Poly_NNP (_( A_DT )_) +_NN mRNA_NN
          was_VBD isolated_VBN from_IN ~_NN 800_CD μg_NN of_IN total_JJ RNA_NNP using_VBG the_DT
          FastTrack_NNP ®_NN 2_CD ._. 0_CD mRNA_NN Isolation_NNP Kit_NNP (_( Invitrogen_NNP Corp_NNP )_) and_CC
          cDNA_NN was_VBD subsequently_RB generated_VBN using_VBG random_JJ hexamers_NNS as_IN
          primers_NNS and_CC S_NNP UPERS_NNP CRIPTII_NNP ™_NN RNase_NNP H_NNP -_: Reverse_VBP
          Transcriptase_NNP (_( Invitrogen_NNP Corp_NNP )_) ._. The_DT PCR-Select_NNP cDNA_NN
          Subtraction_NNP and_CC PCR-Select_NNP Differential_NNP Screening_NNP Kits_NNP
          (_( Clontech_NNP Laboratories_NNPS Inc_NNP ._. )_) were_VBD used_VBN to_TO enrich_VBP for_IN and_CC
          identify_VB differentially_RB expressed_VBD genes_NNS in_IN the_DT driver_NN and_CC
          tester_NN cDNAs_NNS [_NN 48_CD 49_CD ]_NN ._. Both_DT forward-_NN and_CC
          reverse-subtraction_JJ were_VBD performed_VBN ;_: untreated_JJ HUVEC_NNP cDNA_NN
          served_VBD as_IN driver_NN and_CC VEGF-treated_NNP HUVEC_NNP cDNA_NN served_VBD as_IN
          tester_NN in_IN the_DT former_NN ,_, whereas_IN untreated_JJ HUVEC_NNP cDNA_NN served_VBD
          as_IN tester_NN and_CC VEGF-treated_NNP HUVEC_NNP cDNA_NN served_VBD as_IN driver_NN in_IN
          the_DT latter_JJ [_NN 48_CD 49_CD ]_NN ._. Target_NNP cDNA_NN fragments_NNS were_VBD
          amplified_VBN using_VBG the_DT Marathon_NNP ™_NN cDNA_NN Amplification_NNP Kit_NNP ,_,
          subcloned_JJ into_IN pCR_NN ®_NN 2_CD ._. 1_LS using_VBG the_DT TA_NNP Cloning_NNP ®_NN Kit_NNP and_CC
          transformed_VBN into_IN TOP_NNP 10_CD One_CD Shot_NNP ™_NN competent_JJ cells_NNS (_( all_DT
          from_IN Invitrogen_NNP Corp_NNP )_) ._. DNA_NN sequencings_NNS were_VBD performed_VBN by_IN
          Applied_NNP Biosystems_NNP Model_NNP 373_CD A_DT (_( Lonestar_NNP Lab_NNP )_) ._.
        
        
          Northern_NNP Blot_NNP Analysis_NNP
          HUVECs_NNP were_VBD cultured_JJ in_IN a_DT 3_CD D_NNP collagen_NN matrix_NN for_IN 0_CD ,_,
          12_CD ,_, 24_CD ,_, and_CC 36_CD hours_NNS ,_, with_IN or_CC without_IN VEGF_NNP 165_CD ,_, as_IN
          described_VBN above_IN ._. Northern_JJ blot_NN analysis_NN was_VBD performed_VBN as_RB
          previously_RB described_VBD [_NN 31_CD ]_NN ._. The_DT KDR_NNP probe_NN was_VBD amplified_VBN
          from_IN full-length_JJ KDR_NNP cDNA_NN (_( available_JJ in_IN our_PRP$ laboratory_NN )_) ._.
          The_DT other_JJ probes_NNS were_VBD amplified_VBN from_IN untreated_JJ HUVEC_NNP cDNA_NN
          which_WDT was_VBD generated_VBN from_IN total_JJ RNA_NNP by_IN RT-PCR_NNP ,_, as_IN
          described_VBN above_IN ._. Oligonucleotide_NNP primers_NNS used_VBN for_IN probe_NN
          amplification_NN from_IN cDNA_NN are_VBP shown_VBN in_IN Table_NNP II_NNP ._.
        
        
          Western_NNP Immunoblot_NNP Analysis_NNP
          HUVEC_NNP monolayers_NNS were_VBD either_CC left_VBD untreated_JJ or_CC were_VBD
          treated_VBN with_IN 100_CD ng_NN /_NN ml_NN of_IN VEGF_NNP or_CC bFGF_NN ,_, or_CC with_IN 20_CD ng_NN /_NN ml_NN
          of_IN PMA_NNP every_DT 6_CD hours_NNS for_IN 48_CD hours_NNS ._. Monolayers_NNP were_VBD then_RB
          washed_VBN with_IN cold_JJ PBS_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, and_CC solubilized_JJ in_IN 1_CD ._. 0_CD ml_NN
          of_IN cell_NN extraction_NN buffer_NN (_( 50_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 1_CD %_NN Triton_NNP
          X-_NNP 100_CD ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, 0_CD ._. 25_CD %_NN deoxycholate_NN ,_, 150_CD mM_NN sodium_NN
          chloride_NN ,_, 1_CD mM_NN EDTA_NNP ,_, and_CC protease_NN inhibitors_NNS ._. Equal_NNP
          quantities_NNS of_IN clarified_VBN proteins_NNS were_VBD resolved_VBN by_IN
          SDS-PAGE_NNP under_IN reducing_VBG conditions_NNS and_CC transferred_VBN to_TO a_DT
          nitrocellulose_NN membrane_NN ._. Antigen-antibody_NNP complexes_NNS were_VBD
          detected_VBN as_IN described_VBN previously_RB [_NN 46_CD 47_CD ]_NN ._.
        
      
      
        Abbreviations_NNP
        EC_NNP ,_, endothelial_NN cell_NN ;_: MMP_NNP ,_, matrix_NN metalloproteinases_NNS ;_:
        3_CD D_NNP ,_, three-dimensional_JJ ;_: KDR_NNP ,_, kinase_NN domain_NN receptor_NN ;_: SSHDD_NNP ,_,
        suppression_NN subtractive_JJ hybridization_NN followed_VBN by_IN
        differential_NN display_NN ;_: VE-cadherin_NNP ,_, vascular_NN
        endothelial-cadherin_JJ ;_: PMA_NNP ,_, phorbol_NN 12_CD -_: myristate_NN 13_CD -_: acetate_NN ;_:
        VEGF_NNP ,_, vascular_NN endothelial_NN growth_NN factor_NN ;_: bFGF_NN ,_, basic_JJ
        fibroblast_NN growth_NN factor_NN ._.
      
      
        Authors_NNP '_'' contributions_NNS
        KKW_NNP was_VBD responsible_JJ for_IN preparation_NN of_IN SSHDD_NNP ,_, northern_JJ
        blot_NN ,_, data_NNS analyses_NNS ,_, and_CC manuscript_NN preparation_NN ._. GDT_NNP was_VBD
        responsible_JJ for_IN DNA_NNP subcloning_VBG ,_, northern_JJ blot_NN analysis_NN ,_, DNA_NNP
        sequencing_VBG ,_, and_CC BLAST_NN algorithm_NN analysis_NN ._. JOH_NNP performed_VBD
        RT-PCR_NNP and_CC Western_NNP immunoblotting_VBG assays_NNS ._. JY_NNP performed_VBD
        RT-PCR_NNP ,_, northern_JJ and_CC DNA_NNP sequencing_VBG analysis_NN ._. All_DT authors_NNS
        read_VBP and_CC approved_VBD the_DT manuscript_NN ._.
      
    
  
